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E-Cigarettes, Vaping, and Youth
The Family Smoking Prevention and Tobacco Control
Act of 2009 empowered the US Food and Drug
Administration (FDA) to regulate tobacco, the leading
preventable cause of death. The agency, however, ini-
tially exercised authority only over specific tobacco
products: cigarettes, cigarette tobacco, roll-your-own
(loose tobacco), and smokeless tobacco. This decision
left other forms of tobacco unregulated. Five years
later, in April 2014, the FDA sought to close this regula-
tory gap by issuing proposed rules—referred to as
“deeming”—to regulate electronic cigarettes, cigars,
pipe tobacco, nicotine gels, waterpipe (hookah)
tobacco, and orally ingested dissolvable tobacco prod-
ucts. The proposed rules represent a watershed
moment in tobacco control but do not go far enough in
regulating e-cigarettes, a product with uncertain ben-
efits and potentially significant harms.
As their usage has increased substantially,
e-cigarettes have spurred enormous controversy.1
E-cigarettes, which vary in power and potency, typi-
callycontainanicotine-based liquid that isvaporizedand
inhaled.Public health advocateshavedebatedwhether
e-cigarettes are effective harm reduction tools or offer
a pathway to smoking. By delivering nicotine andmim-
icking oral inhalation, e-cigarettes could reduce depen-
dency on combustible cigarettes and prevent relapse.
Alternatively, e-cigarettes could become a gateway to
smokingbyexposingyoungpeople to theworldofnico-
tine and relegitimizing tobacco use in society. Probably
both scenarios are true: e-cigarettes can help older, en-
trenched smokers to quit smoking, whereas younger
nonsmokers could transition from electronic to com-
bustible cigarettes once they are addicted to nicotine.
FDA Proposed Rule
Asproposed, theFDAruleswouldseta federalminimum
age of 18 years to use e-cigarettes, require identification
topurchase them(currently, justmore thanhalfof states
imposeagerestrictions),prohibitmostsalesinvendingma-
chines,mandatewarninglabelsonpackaging,andprohibit
manufacturers fromproviding free samples.
Companies would be required to register
e-cigarettes with the FDA, submit safety data, and dis-
closeproduct ingredients. FDA inspectorswouldmoni-
tor compliance. Companieswould be able to introduce
new products to themarket only after FDA review and
approval. Further, companies would be permitted to
make claims for reduced risk only if the agency con-
firms the claim based on scientific evidence while also
finding a benefit to the health of the public.
Although a vital step forward, the proposed rules
leave major issues unanswered, notably those regard-
ing the use of flavored nicotine and marketing prac-
tices.Bycontrast, inFebruary2014, theEuropeanUnion
issuedaTobaccoProductsDirective tosafeguardyouth,
includingbansonadvertising,promotingtaste,andnico-
tine flavorings fore-cigarettes.2Other countries, includ-
ing Brazil, Lebanon, and Singapore, have banned
e-cigarettes entirely.
A lengthyrule-makingprocesshascompoundedthe
concerns associated with the proposed rules. Mired in
litigation, the FDA has been working since 2011 to ex-
tend its deeming authority, and it may be years before
the proposed rules are finalized. Even then, the FDA
plans towait2yearsbeforeenforcingwarning labelsand
requiring manufacturers to submit product applica-
tions. In the interim, new products will be permitted to
enter the market without preapproval,
while the popularity of youth “vaping,”
the colloquial term for e-cigarette use,
continues to increase.
Balancing BenefitsWith Harms
Preliminary evidence demonstrates the
potential of e-cigarettes to reduceharm
by weaning smokers from combustible
tobacco, but the benefits appear minimal. At the same
time, evidence of harm is emerging. More powerful
e-cigarettes, commonly known as tank systems, heat
nicotine liquid hot enough to produce cancer-causing
carcinogens, such as formaldehyde and acetaldehyde,
in their vapor.3 Further, in a study of human bronchial
cells that contained some mutations found in smokers
at risk of lung cancer, scientists found a pattern of gene
expression in cells grown in a medium exposed to e-
cigarette vapor that was similar to the pattern found in
cells grown in a medium exposed to combustible to-
bacco smoke.4 In addition, the virulence of drug-
resistant bacteria can be increased by e-cigarette va-
pors and affect the ability of cells to destroy bacteria.5
TheCenters forDiseaseControl andPrevention re-
ported an increase in calls to poison control centers af-
ter unintentional exposure of children to e-liquid, in-
cluding oral ingestion, eye contact, and inhalation
exposure.6 Public reports commonly associated with
e-cigarettes includetroublebreathing,headache,cough,
dizziness, sore throat, nose bleeds, chest pain, heart
palpitations,7 andallergic reactionssuchas itchinessand
lip swelling. The conundrum is how to regulate
e-cigarettes given scientific uncertainty about the na-
ture and extent of harms.
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ANewYouth Culture of Vaping
The increasingpopularityof vapinghasbeenassociatedwitha surge
in nicotine use among adolescents. It took decades of social mobili-
zationandpolitical action toovercome theperceptionof smokingas
“cool,” even after the evidence became clear that smoking is deadly.
That intensive campaign—supported by smoke-free laws, advertis-
ingbans,andpackagewarnings—couldeasilybereversedbythepopu-
larity of vaping. Even though today’s youth grew up inculcatedwith
negativesocial stigmaaroundtheuseofcombustiblecigarettes,vap-
ingproductsareoftenmarketedashighlypalatableandaccessibleal-
ternatives. In recent years, tobacco companies such as Altria as well
asnichemanufacturers likeNJoyhaveaggressivelyenteredthismar-
ket by reinventing brand appeal and normalizing vaping.
With the decline in recent years in the prevalence of young to-
bacco smokers—themost profitable long-term consumers—it is no
surprise that youth are a key demographic of the vaping campaign.
Colorful advertisements touting flavors suchasbubble gumorwith
celebrity actors conjure imagesof JoeCamel and theMarlboroMan.
The industry skirts accusations of deliberately catering to youthful
consumers by asserting that e-cigarettes are a safer alternative to
combustible cigarettes or positioning e-cigarettes as nicotine re-
placement therapies.8
The Centers for Disease Control and Prevention reported that
between2011 and2012, theproportionofhighschool studentswho
had triede-cigarettesdoubled from4.7%to 10%.9Althoughalarm-
ing, this figure significantlyunderestimates theproliferationofnico-
tine intake by vaping among adolescents. The study directly ad-
dressed e-cigarettes but left out a related class of devices that also
create a nicotine vapor: e-hookahs, hookah pens, and vape pipes.
The failure of adolescents to equate vaping products generally
with e-cigarettes underscores how successful the tobacco indus-
tryhasbeen in reinventing apopular “smoking” trend. TheFDAem-
phasizes the power of social norms in influencing behavior. For in-
stance, the agency points to the “value of strict access restrictions”
to “symbolize and reinforce an emerging social norm that disap-
proves of tobacco use.”10However, by failing to restrict advertising
and flavored nicotine for e-cigarettes, the agency could be under-
mining its own conclusions. Child-friendly flavors and slick promo-
tionsmightencourageyoungpeople toexperimentwithvapingand
potentially increase smoking rates among youth. This outcome ap-
pears inconsistentwith the FDAemphasis on creating social norms
to limit the proliferation of tobacco.
Important Next Steps
Theoral satisfactionofe-cigarettes, togetherwith their ability tode-
liver nicotine without combusting tobacco, poses a double-edged
swordforpublichealth.Although itwillbeeasier toreplaceonehighly
dangerous addiction (cigarettes) with a seemingly less dangerous
alternative (e-cigarettes), the same dynamics may recruit many
young people, addicting them to nicotine, with some transitioning
to combustible tobacco. There is also amajor risk that e-cigarettes
will revive the popular smoking culture that has taken decades to
dismantle.
The FDA deeming proposal offers the welcome promise of a
regulatory structure to ensure that e-cigarettes and other vaping
products are safe and effective. However, the agency shouldmove
boldly and rapidly to prevent companies from exploiting youth. By
bolstering the proposed rules to limit advertising and prohibit fla-
vorednicotine, theagencycouldpreventproliferationofe-cigarette
use among adolescents, while not undermining its regulatory goal
of reducingharm.Before thecommentperiodontheproposedrules
closes in July, thepublichealthcommunity should speakwithaclear
voicetourgemeaningfulandeffectiveregulationtoprotectUSyouth
against the reinvention of Big Tobacco.
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